We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ID NOW

News List

Abbott Releases ID NOW COVID-19 Interim Clinical Study Results americanpharmaceuticalreview
October 14, 2020
In a continuing effort to provide the facts about ID NOW to support public health interests, Abbott is sharing new interim clinical data results on its ID NOW COVID-19 rapid test.
Abbott Releases Interim Study Data on ID NOW COVID-19 Rapid Test americanpharmaceuticalreview
May 28, 2020
Abbott announced an interim analysis of an ongoing multi-site clinical study in urgent care clinics that indicates its ID NOW COVID-19 rapid test is showing strong agreement to lab-based molecular polymerase chain reaction (PCR) instruments.
FDA Warns of Possible Accuracy Concerns with Abbott ID NOW Test americanpharmaceuticalreview
May 18, 2020
The U.S. Food and Drug Administration (FDA) is alerting the public to early data that suggest potential inaccurate results from using the Abbott ID NOW point-of-care test to diagnose COVID-19. Specifically, the test may return false negative results.